Odd Kelly,
You are exactly correct about the obvious buying late Thursday. Some had advance knowledge that an announcement was coming. What struck me the most on Friday was the naivete on the part of some buyers, when the share price was run up to 26 cents. The thrust of Friday's announcement concerned a saliva test that may or may not ever materialize, at some future time, in a benefitual way to shareholders. The chances that some of the stock purchased on Friday being underwater soon is high. I am shocked that the run-up buyers on Friday do not appear to understand that basic principle of investing in biotechs. kag